Skip to main content

Advertisement

SpringerLink
Log in

Non-surgical treatment as an alternative for the management of central giant cell granuloma: a systematic review

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objective

To evaluate the effectiveness of non-surgical treatment as an alternative in the management of central giant cell granuloma (CGCG).

Material and methods

A literature search was carried out in accordance with the PRISMA statement in order to answer the question “Are non-surgical treatments effective as an alternative in the treatment of CGCG?”. Two examiners independently assessed eligibility, risk of bias, and extracted data, which included therapeutic protocol, side effects, and need for surgical supplementation.

Results

Among 1712 studies, 15 were included, totaling 145 patients. Calcitonin, intralesional corticosteroids, and denosumab were the medications used. For calcitonin (n = 61), complete remission was found in 30 cases. For intralesional triamcinolone (n = 68), reduction in size was observed in most cases (n = 39). Four cases received subcutaneous denosumab and showed absence of active bone metabolism in the region, of which three presented ossification. Combination of drug therapies (n = 29) was reported in one study and included subcutaneous interferon and oral imatinib. More and less side effects were found for interferon and corticosteroids, respectively. Forty percent of patients required additional surgical treatment.

Conclusion

Despite the side effects presented and the need for additional surgery in some patients, in general, all non-surgical treatments could provide positive results as an alternative for the management of CGCG, especially with regard to reducing the size of the lesion.

Clinical relevance

CGCG is a benign bone lesion that mainly affects young individuals. Although the most common therapy is surgery, its contraindication in some patients, the large extension, and high recurrence rate of the aggressive variant have led the search for non-surgical therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Speight PM, Takata T (2018) New tumor entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Archiv 472:331–339. https://doi.org/10.1007/s00428-017-2182-3

  2. Chrcanovic BR, Gomes CC, Gomez RS (2018) Central giant cell lesion of the jaws: An updated analysis of 2270 cases reported in the literature. J Oral Pathol Med 47:731–739. https://doi.org/10.1111/jop.12730

    Article  PubMed  Google Scholar 

  3. Stavropoulos F, Katz J (2002) Central giant cell granulomas: A systematic review of the radiographic characteristics with the addition of 20 new cases. Dentomaxillofac Radiol 31:213–217. https://doi.org/10.1038/sj.dmfr.4600700

    Article  PubMed  Google Scholar 

  4. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A (1986) Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg 44:708–713. https://doi.org/10.1016/0278-2391(86)90040-6

    Article  PubMed  Google Scholar 

  5. Jaffe HL (1953) Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol 6:159–175. https://doi.org/10.1016/0030-4220(53)90151-0

    Article  PubMed  Google Scholar 

  6. Schreuder WH, van den Berg H, Westermann AM, Peacock ZS, de Lange J (2017) Pharmacological and surgical therapy for the central giant cell granuloma: A long-term retrospective cohort study. J Craniomaxillofac Surg 45:232–243. https://doi.org/10.1016/j.jcms.2016.11.011

    Article  PubMed  Google Scholar 

  7. Balaji P, Balaji SM (2019) Central giant cell granuloma - A case report. Indian J Dent Res 30:130–132. https://doi.org/10.4103/ijdr.IJDR_61_19

    Article  PubMed  Google Scholar 

  8. Gupta B, Stanton N, Coleman H, White C, Singh J (2015) A novel approach to the management of a central giant cell granuloma with denosumab: A case report and review of current treatments. J Craniomaxillofac Surg 43:1127–1132. https://doi.org/10.1016/j.jcms.2015.04.011

    Article  PubMed  Google Scholar 

  9. Suárez-Roa MDL, Reveiz L, Rivera LMR et al (2009) Interventions for central giant cell granuloma (CGCG) of the jaws. Cochrane Database Syst Rev 7:CD0007404. https://doi.org/10.1002/14651858.CD007404.pub2

  10. Eisenbud L, Stern M, Rothberg M, Sachs SA (1988) Central giant cell granuloma of the jaws: experiences in the management of thirty-seven cases. J Oral Maxillofac Surg 46:376–384. https://doi.org/10.1016/0278-2391(88)90221-2

    Article  PubMed  Google Scholar 

  11. Terry BC, Jacoway J (1996) Management of central giant cell lesions: An alternative to surgical therapy. Oral Maxillofac Surg Clin North Am 6:579–601

    Article  Google Scholar 

  12. de Lange J, van den Akker HP, Veldhuijzen van Zanten GO et al (2006) Calcitonin therapy in central giant cell granuloma of the jaw: a randomized double-blind placebo-controlled study. Int J Oral Maxillofac Surg 35:791–795. https://doi.org/10.1016/j.ijom.2006.03.030

    Article  PubMed  Google Scholar 

  13. de Lange J, van den Akker HP, van den Berg H (2007) Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Endod 104:603–615. https://doi.org/10.1016/j.tripleo.2007.04.003

    Article  Google Scholar 

  14. Sezer B, Koyuncu B, Gomel M, Güngay T (2005) Intralesional corticosteroid injection for central giant cell granuloma: a case report and review of the literature. Turk J Pediatr 47:75–81

    PubMed  Google Scholar 

  15. Nogueira RLM, Faria MHG, Osterne RLV, Cavalcante RB, Ribeiro RA, Rabenhorst SHB (2012) Glucocorticoid and calcitonin receptor expression in central giant cell lesions: implications for therapy. Int J Oral Maxillofac Surg 41:994–1000. https://doi.org/10.1016/j.ijom.2012.01.017

    Article  PubMed  Google Scholar 

  16. O’Connell JE, Kearns GJ (2013) Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases. Int J Med Sci 82:163–170. https://doi.org/10.1007/s11845-012-0858-x

    Article  Google Scholar 

  17. Thomas D, Henshaw R, Skubitz K et al (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11:275–280. https://doi.org/10.1016/S1470-2045(10)70010-3

    Article  PubMed  Google Scholar 

  18. Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18:e1003583. https://doi.org/10.1371/journal.pmed.1003583

    Article  PubMed  PubMed Central  Google Scholar 

  19. Higgins JPT, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928

    Article  PubMed  PubMed Central  Google Scholar 

  20. Chandler J, McKenzie J, Boutron I, Welch V (editors) (2016) Cochrane Methods. Cochrane Database of Syst Rev 10 (Suppl 1).https://doi.org/10.1002/14651858.CD201601

  21. Wells GA, Shea B, O`Connell D, Peterson J, Welch V, Losos M, Tugwell P (2021) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 06 May 2021

  22. Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Lisy K, Qureshi R, Mattis P, Mu P (2020) Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, eds. JBI Manual for Evidence Synthesis. The Joanna Briggs Institute. https://doi.org/10.46658/JBIMES-20-08. Accessed 06 May 2021

  23. Crestanello Nese JP, Fernandez Luzardo CF, Robano Navatta AR (2004) Corticoides intralesionales en lesiones a células gigantes. Rev Esp Cirug Oral y Maxilofac 25:351–360

    Google Scholar 

  24. Borges HO, Machado RA, Vidor MM, Beltrão RG, Heitz C, Sant’Ana MF, (2008) Calcitonin: a non-invasive giant cells therapy. Int J Pediatr Otorhinolaryngol 72:959–963. https://doi.org/10.1016/j.ijporl.2008.03.016

    Article  PubMed  Google Scholar 

  25. de Lange J, Rosenberg AJ, van den Akker HP, Koole R, Wirds JJ, van den Berg H (1999) Treatment of central giant cell granuloma of the jaw with calcitonin. Int J Oral Maxillofac Surg 28:372–376. https://doi.org/10.1034/j.1399-0020.1999.285280513.x

    Article  PubMed  Google Scholar 

  26. Rosenberg AJ, Bosschaart AN, Jacobs JW, Wirds JJ, Koole R (1997) Calcitonine therapie bij grote of recidiverende centrale reuzencelgranulomen van de onderkaak [Calcitonin therapy in large or recurrent central giant cell granulomas of the lower jaw]. Ned Tijdschr Geneeskd 141:335–339

    PubMed  Google Scholar 

  27. Cavalcante IL, Barros CCS, Rodrigues KAM et al (2018) Quantification of bone gain in central giant cell granuloma of the jaws submitted to intralesional corticotherapy. J Bras Patol Med Lab 54:183–188. https://doi.org/10.5935/1676-2444.20180032

    Article  Google Scholar 

  28. Dolanmaz D, Esen A, Mihmanli A, Işık K (2016) Management of central giant cell granuloma of the jaws with intralesional steroid injection and review of the literature. Oral Maxillofac Surg 20:203–209. https://doi.org/10.1007/s10006-015-0530-5

    Article  PubMed  Google Scholar 

  29. Bredell M, Rordorf T, Kroiss S, Rüker M, Zweifel DF, Rostetter C (2018) Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study. J Oral Maxillofac Surg 76:775–784. https://doi.org/10.1016/j.joms.2017.09.013

    Article  PubMed  Google Scholar 

  30. Allon DM, Anavi Y, Calderon S (2009) Central giant cell lesion of the jaw: nonsurgical treatment with calcitonin nasal spray. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:811–818. https://doi.org/10.1016/j.tripleo.2009.02.013

    Article  PubMed  Google Scholar 

  31. Pogrel MA (2003) Calcitonin therapy for central giant cell granuloma. J Oral Maxillofac Surg 61:649–654. https://doi.org/10.1053/joms.2003.50129

    Article  PubMed  Google Scholar 

  32. Vered M, Shohat I, Buchner A, Dayan D, Taicher S (2007) Calcitonin nasal spray for treatment of central giant cell granuloma: clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:226–239. https://doi.org/10.1016/j.tripleo.2006.05.020

    Article  PubMed  Google Scholar 

  33. Nogueira RLM, Osterne RLV, Lima Verde RMB, Azevedo NO, Teixeira RC, Cavalcante RB (2020) Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant cell lesions: a prospective study. Br J Oral Maxillofac Surg 58:e283–e289. https://doi.org/10.1016/j.bjoms.2020.07.032

    Article  PubMed  Google Scholar 

  34. Tawfik MA, Gaballah ETM, Bilal M (2004) Treatment of central giant cell granuloma of the mandible with intralesional injection of corticosteroid. Egypt Dent J 50:687–699

    Google Scholar 

  35. Harris M (1993) Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg 31:89–94. https://doi.org/10.1016/0266-4356(93)90168-v

    Article  PubMed  Google Scholar 

  36. Maeda A, Matsui H, Kanamori M, Yudoh K, Tsuji H (1994) Calcitonin receptors on neoplastic mononuclear cells cultured from a human giant-cell tumor of the sacrum. J Cancer Res Clin Oncol 120:272–278. https://doi.org/10.1007/BF01236383

    Article  PubMed  Google Scholar 

  37. Esen A, Işık K, Dolanmaz D (2015) Treatment of mouth and jaw diseases with intralesional steroid injection. World J Stomatol 4:87–95. https://doi.org/10.5321/wjs.v4.i2.87

    Article  Google Scholar 

  38. Jacoway JR, Howell FV, Terry BC (1988) Central giant cell granuloma: an alternative to surgical therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 66:572

    Google Scholar 

  39. Abdo EN, Alves LC, Rodrigues AS, Mesquita RA, Gomez RS (2005) Treatment of a central giant cell granuloma with intralesional corticosteroid. Br J Oral Maxillofac Surg 43:74–76. https://doi.org/10.1016/j.bjoms.2004.08.015

    Article  PubMed  Google Scholar 

  40. Adornato MC, Paticoff KA (2001) Intralesional corticosteroid injection for treatment of central giant-cell granuloma. J Am Dent Assoc 132:186–190. https://doi.org/10.14219/jada.archive.2001.0153

    Article  PubMed  Google Scholar 

  41. Carlos R, Sedano HO (2002) Intralesional corticosteroids as an alternative treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:161–166. https://doi.org/10.1067/moe.2002.119971

    Article  PubMed  Google Scholar 

  42. Kermer C, Millesi W, Watzke IM (1994) Local injection of corticosteroids for central giant cell granuloma. A case report. Int J Oral Maxillofac Surg 23:366–368. https://doi.org/10.1016/s0901-5027(05)80057-8

    Article  PubMed  Google Scholar 

  43. Rajeevan NS, Soumithran CS (1998) Intralesional corticosteroid injection for central giant cell granuloma: A case report. Int J Oral Maxillofac Surg 27:303–304. https://doi.org/10.1016/S0901-5027(05)80620-4

    Article  PubMed  Google Scholar 

  44. Osterne RL, Araújo PM, Souza-Carvalho AC, Cavalcante RB, Sant’Ana E, Nogueira RLM, (2013) Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws: A meta-analytic study. Med Oral Patol Oral Cir Bucal 18:e226–e232. https://doi.org/10.4317/medoral.18345

    Article  PubMed  PubMed Central  Google Scholar 

  45. Chawla S, Blay J, Rutkowski P et al (2019) Denosumab in patients with giant-cell tumour fo bone: a multicentre, open-laber, phase 2 study. Lancet Oncol 20:P1719-1729. https://doi.org/10.1016/S1470-2045(19)30663-1

    Article  Google Scholar 

  46. Folkman J, Mulliken JB, Ezekowitz RAB (1997) Antiangiogenic therapy of haemangiomas with interferon A. In: Stuart-Harris R, Penny R (eds) The Clinical Applications of the Interferons. Chapman & Hall Medical, London, pp 255–265

    Google Scholar 

  47. Kaban LB, Troulis MJ, Ebb D, August M, Hornicek FJ, Dodson TB (2002) Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg 60:1103–1113. https://doi.org/10.1053/joms.2002.34975

    Article  PubMed  Google Scholar 

  48. Kaban LB, Troulis MJ, Wilkinson MS, Ebb D, Dodson TB (2007) Adjuvant antiangiogenic therapy for giant cell tumors of the jaws. J Oral Maxillofac Surg 65:2018–2024. https://doi.org/10.1016/j.joms.2007.03.030

    Article  PubMed  Google Scholar 

  49. Kaban LB, Mulliken JB, Ezekowitz RA, Ebb D, Smith PS, Folkman J (1999) Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics 103:1145–1149. https://doi.org/10.1542/peds.103.6.1145

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior)—n° 88882.448733/2019–01—Brazil.

Author information

Authors and Affiliations

  1. Department of Dentistry, Maringá State University, Avenida Mandacaru, Maringá, Paraná, 87080-000, Brazil

    Camila Camarini & Elen de Souza Tolentino

Authors
  1. Camila Camarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elen de Souza Tolentino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Camila Camarini.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

Conflict of interest

Author Camila Camarini declares that she has no conflict of interest. Author Elen de Souza Tolentino declares that she has no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 31 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Camarini, C., de Souza Tolentino , E. Non-surgical treatment as an alternative for the management of central giant cell granuloma: a systematic review. Clin Oral Invest 26, 2111–2132 (2022). https://doi.org/10.1007/s00784-021-04193-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-021-04193-z

Keywords

Search

Navigation